10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
CIGNA GROUP | |||
Ticker: CI Fiscal Year: 2019 | |||
Consolidated Statements of Income | |||
Period Ending Dec 31, 2019 10-K (Filed: Feb 27, 2020) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | |
| Revenues | |||
| Premiums | $ 39,714 | 36,113 | 32,491 |
| Net investment income | 1,390 | 1,480 | 1,226 |
| Total revenues | 153,566 | 48,650 | 41,806 |
| Benefits and Expenses | |||
| Pharmacy and other service costs | 97,668 | 4,793 | 2,456 |
| Medical costs and other benefit expenses | 30,819 | 27,528 | 25,263 |
| Selling, general and administrative expenses | 14,053 | 11,934 | 10,030 |
| Amortization of other acquired intangible assets | 2,949 | 235 | 115 |
| Total benefits and expenses | 145,489 | 44,490 | 37,864 |
| Income from operations | 8,077 | 4,160 | 3,942 |
| Interest expense and other | (1,682) | (498) | (252) |
| Debt extinguishment costs | (2) | 0 | (321) |
| Net realized investment gains (losses) | 177 | (81) | 237 |
| Income (loss) before income taxes | 6,570 | 3,581 | 3,606 |
| Total income taxes | 1,450 | 935 | 1,374 |
| Net Income | 5,120 | 2,646 | 2,232 |
| Less: net income (loss) attributable to noncontrolling interests | 16 | 9 | (5) |
| Shareholders' net income | 5,104 | 2,637 | 2,237 |
| Shareholders' net income per share: | |||
| Basic | 13.58 | 10.69 | 8.92 |
| Diluted | 13.44 | 10.54 | 8.77 |
| Product Or Service | |||
| Fees and other revenues | |||
| Pharmacy revenues, fees and other revenues | 9,363 | 5,578 | 5,110 |
| Pharmacy revenues | |||
| Pharmacy revenues, fees and other revenues | 103,099 | 5,479 | 2,979 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
CIGNA GROUP | |||
Ticker: CI Fiscal Year: 2019 | |||
Consolidated Statements of Comprehensive Income | |||
Period Ending Dec 31, 2019 10-K (Filed: Feb 27, 2020) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | |
| Net Income | $ 5,120 | 2,646 | 2,232 |
| Other comprehensive income (loss), net of tax | |||
| Net unrealized appreciation (depreciation) on securities and derivatives | 957 | (365) | (37) |
| Net translation (losses) gains on foreign currencies | (59) | (167) | 301 |
| Postretirement benefits liability adjustment | (133) | 127 | 33 |
| Other comprehensive income (loss), net of tax | 765 | (405) | 297 |
| Total comprehensive income | 5,885 | 2,241 | 2,529 |
| Comprehensive income (loss) attributable to noncontrolling interests: | |||
| Net income (loss) attributable to redeemable noncontrolling interests | 11 | 9 | 0 |
| Net income (loss) attributable to other noncontrolling interests | 5 | 0 | (5) |
| Other comprehensive income (loss) attributable to redeemable noncontrolling interests | (5) | (15) | (3) |
| Total comprehensive income (loss) attributable to noncontrolling interests | 11 | (6) | (8) |
| Shareholders' comprehensive income (loss) | 5,874 | 2,247 | 2,537 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
CIGNA GROUP | |||
Ticker: CI Fiscal Year: 2019 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 31, 2019 10-K (Filed: Feb 27, 2020) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | |
| Cash Flows from Operating Activities | |||
| Net Income | $ 5,120 | 2,646 | 2,232 |
| Adjustments to reconcile net income to net cash provided by (used in) operating activities: | |||
| Depreciation and amortization | 3,651 | 695 | 566 |
| Realized investment (gains) losses | (177) | 81 | (237) |
| Deferred income taxes (benefits) | (313) | (101) | 242 |
| Debt extinguishment costs | 2 | 0 | 321 |
| Net changes in assets and liabilities, net of non-operating effects: | |||
| Accounts receivable | (713) | 705 | (233) |
| Inventories | 149 | (107) | (72) |
| Deferred policy acquisition costs | (242) | (237) | (282) |
| Reinsurance recoverables and other assets | (277) | (234) | 115 |
| Insurance liabilities | 575 | 560 | 506 |
| Pharmacy and service costs payable | (192) | (842) | 35 |
| Accounts payable, accrued expenses and other liabilities | 1,343 | 332 | 696 |
| Other, net | 559 | 272 | 197 |
| Net cash provided by (used in) operating activities | 9,485 | 3,770 | 4,086 |
| Cash Flows from Investing Activities | |||
| Proceeds from investments sold: | |||
| Debt securities and equity securities | 3,487 | 2,655 | 2,012 |
| Investment maturities and repayments: | |||
| Debt securities and equity securities | 1,825 | 2,151 | 2,051 |
| Commercial mortgage loans | 199 | 215 | 335 |
| Other sales, maturities and repayments (primarily short-term and other long-term investments) | 1,311 | 734 | 1,702 |
| Investments purchased or originated: | |||
| Debt securities and equity securities | (4,282) | (5,637) | (5,628) |
| Commercial mortgage loans | (307) | (312) | (430) |
| Other (primarily short-term and other long-term investments) | (1,753) | (1,189) | (1,065) |
| Property and equipment purchases | (1,050) | (528) | (471) |
| Acquisitions, net of cash acquired | (153) | (24,455) | (209) |
| Other, net | (11) | (12) | 0 |
| Net cash provided by (used in) investing activities | (734) | (26,378) | (1,703) |
| Cash Flows from Financing Activities | |||
| Deposits and interest credited to contractholder deposit funds | 955 | 1,040 | 1,230 |
| Withdrawals and benefit payments from contractholder deposit funds | (1,097) | (1,151) | (1,363) |
| Net change in short-term debt | (681) | 1,487 | 80 |
| Payments for debt extinguishment | (3) | 0 | (313) |
| Repayment of long-term debt | (4,491) | (131) | (1,250) |
| Net proceeds on issuance of long-term debt | 0 | 22,856 | 1,581 |
| Repurchase of common stock | (1,987) | (342) | (2,725) |
| Issuance of common stock | 224 | 68 | 131 |
| Other, net | (107) | (312) | (22) |
| Net cash provided by (used in) financing activities | (7,187) | 23,515 | (2,651) |
| Effect of foreign currency rate changes on cash and cash equivalents | (8) | (24) | 55 |
| Net increase (decrease) in cash, cash equivalents and restricted cash | 1,556 | 883 | (213) |
| Cash, cash equivalents and restricted cash, January 1, | 3,855 | 2,972 | |
| Cash, cash equivalents and restricted cash, ending balance | 5,411 | 3,855 | 2,972 |
| Cash reclassified to assets held for sale | (743) | 0 | 0 |
| Cash, cash equivalents, and restricted cash per Consolidated Balance Sheets | 4,668 [1] | 3,855 | 2,972 |
| Supplemental Disclosure of Cash Information: | |||
| Income taxes paid, net of refunds | 1,776 | 1,019 | 1,036 |
| Interest paid | 1,645 | 267 | 240 |
| [1] Includes restricted cash of $26 million reported in Other noncurrent assets and $23 million reported in Long-term investments as of December 31, 2019. | |||
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
CIGNA GROUP | ||
Ticker: CI Fiscal Year: 2019 | ||
Consolidated Balance Sheets | ||
Period Ending Dec 31, 2019 10-K (Filed: Feb 27, 2020) | ||
| (In Millions, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2019 | Dec 31, 2018 | |
| Assets | ||
| Cash and cash equivalents | $ 4,619 | 3,855 |
| Investments | 937 | 2,045 |
| Accounts receivable, net | 10,716 | 10,473 |
| Inventories | 2,661 | 2,821 |
| Other current assets | 1,400 | 1,236 |
| Assets of business held for sale | 9,512 | 0 |
| Total current assets | 29,845 | 20,430 |
| Long-term investments | 21,542 | 26,929 |
| Reinsurance recoverables | 5,100 | 5,507 |
| Deferred policy acquisition costs | 2,958 | 2,821 |
| Property and equipment | 4,417 | 4,562 |
| Goodwill | 44,602 | 44,505 |
| Other intangible assets | 36,562 | 39,003 |
| Other assets | 2,283 | 1,630 |
| Separate account assets | 8,465 | 7,839 |
| TOTAL ASSETS | 155,774 | 153,226 |
| Liabilities: | ||
| Current insurance and contractholder liabilities | 4,921 | 6,801 |
| Pharmacy and service costs payable | 10,454 | 10,702 |
| Accounts payable | 5,090 | 4,366 |
| Accrued expenses and other liabilities | 7,347 | 7,071 |
| Short-term debt | 5,514 | 2,955 |
| Liabilities of business held for sale | 6,812 | 0 |
| Total current liabilities | 40,138 | 31,895 |
| Non-current insurance and contractholder liabilities | 16,052 | 19,974 |
| Deferred tax liabilities, net | 9,387 | 9,453 |
| Other non-current liabilities | 4,460 | 3,470 |
| Long-term debt | 31,893 | 39,523 |
| Separate account liabilities | 8,465 | 7,839 |
| TOTAL LIABILITIES | 110,395 | 112,154 |
| Contingencies - Note 22 | ||
| Redeemable noncontrolling interests | 35 | 37 |
| Shareholders' Equity | ||
| Common stock | 4 | 4 [1] |
| Additional paid-in capital | 28,306 | 27,751 |
| Accumulated other comprehensive income (loss) | (941) | (1,711) |
| Retained earnings | 20,162 | 15,088 |
| Less: treasury stock, at cost | (2,193) | (104) |
| TOTAL SHAREHOLDERS' EQUITY | 45,338 | 41,028 |
| Other noncontrolling interests | 6 | 7 |
| Total equity | 45,344 | 41,035 |
| Total liabilities and shareholders' equity | 155,774 | 153,226 |
| [1] Par value per share, $0.01; shares issued, 386 million as of December 31, 2019 and 381 million as of December 31, 2018; authorized shares; 600 million. | ||
| External Links | |
| CIGNA GROUP (CI) Fiscal Year 2019 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |